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Abstract. A multispectral digital microscope MDM is designed and
constructed as a tool to improve detection of oral neoplasia. The
MDM acquires in vivo images of oral tissue in fluorescence, narrow-
band NB reflectance, and orthogonal polarized reflectance OPR
modes, to enable evaluation of lesions that may not exhibit high con-
trast under standard white light illumination. The device rapidly cap-
tures image sequences so that the diagnostic value of each modality
can be qualitatively and quantitatively evaluated alone and in combi-
nation. As part of a pilot clinical trial, images are acquired from nor-
mal volunteers and patients with precancerous and cancerous lesions.
In normal subjects, the visibility of vasculature can be enhanced by
tuning the reflectance illumination wavelength and polarization. In
patients with histologically confirmed neoplasia, we observe de-
creased blue/green autofluorescence and increased red autofluores-
cence in lesions, and increased visibility of vasculature using NB and
OPR imaging. The perceived lesion borders change with imaging mo-
dality, suggesting that multimodal imaging has the potential to provide
additional diagnostic information not available using standard white
light illumination or by using a single imaging mode alone.
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1 Introduction
Oral cancer poses a significant world health problem, ranking
as the sixth most common cancer globally,1 causing over
127,000 deaths worldwide each year.2 In the United States
alone, there were3 an estimated 30,990 cases of oral cancer
diagnosed and 7430 deaths in 2006. Oral cancer often goes
undiagnosed until the later stages of development, resulting in
high mortality. In the United States, the 5-yr survival rate for
localized oral cancer is 81%, but this drops to only 30% for
advanced disease,4 suggesting that early detection has the
ability to save many lives. In addition, patients who survive
an initial occurrence of oral cancer are known to be at an
increased risk of developing a second malignancy, highlight-
ing the importance of continued surveillance of this
population.5
The most common screening method for oral cancer is
visual inspection and palpation of the mouth. Physicians in-
spect for clinically evident oral lesions such as leukoplakia
white patches or erythroplakia red patches, which are as-
sociated with increased risk of oral cancer.1,6 Visual examina-
tion relies heavily on the experience and skill of the physician
to identify and delineate early premalignant and cancerous
changes. Several benign conditions, such as lichen planus,
inflammation, and hyperkeratosis, mimic the clinical presen-
tation of precancerous lesions, and visual inspection with
standard white light illumination may not yield sufficient con-
trast between normal and abnormal tissues. Once a suspicious
lesion is identified, biopsy and histological examination are
required for definitive diagnosis. Biopsies are invasive, pain-
ful, and costly and require familiarity and skill and are there-
fore typically limited to highly suspicious lesions. Addition-
ally, many lesions are heterogeneous in morphology and
visual appearance, and biopsy diagnosis may not be represen-
tative of the entire lesion due to the small sampling area.7
Approaches that can help differentiate between normal and
neoplastic areas and that can reduce the need for evaluator
experience have the potential to greatly facilitate and improve
early diagnosis of oral cancer.
Optical imaging has the potential to address these clinical
challenges. The contrast between normal and neoplastic areas
can be increased beyond that which is available with standard
white light by tuning illumination and detection conditions.
Reflectance imaging can detect local changes in scattering and
absorption of tissue, and fluorescence imaging can probe
changes in the biochemical composition of tissue by revealing
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levels of endogenous fluorophores. These changes have
shown to be indicative of malignant progression8 and are tar-
geted in a variety of imaging modalities to detect and diag-
nose premalignant changes in different anatomic sites includ-
ing the cervix,9 gastrointestinal tract,10 lung,11 and oral
mucosa.6,8,12–17 High-resolution optical imaging techniques
such as confocal microscopy and optical coherence tomogra-
phy have the potential to image changes in tissue architecture
and cellular morphology. A drawback to in vivo cellular reso-
lution microscopy however, is the small field of view FOV
interrogated, making screening of an entire mucosal surface
impractical without an initial means of guidance toward sus-
picious areas. Wide-field optical imaging techniques enable
clinicians to screen several centimeters at a time for identifi-
cation of margins and optimal sites for further interrogation
by small-FOV imaging techniques or biopsy.
Several wide-field optical imaging systems have shown
promise in improving detection of neoplastic lesions in the
oral and oropharyngeal regions. Lane et al. presented a non-
magnifying hand-held device for direct visualization of oral
cavity tissue fluorescence.6 The system uses a metal-halide
lamp with emission peaks at 405 and 436 nm to excite tissue
autofluorescence. Images obtained using this device showed a
characteristic decrease of green fluorescence associated with
oral precancer and cancer. Decreased green fluorescence dis-
tinguished normal tissue from severe dysplasia, carcinoma in
situ, or invasive carcinoma in 50 biopsy sites from 44 patients
with a sensitivity of 98% and specificity of 100%, using his-
tology as the gold standard. This device is available commer-
cially as the VELscope®, which is Food and Drug Adminis-
tration FDA approved and is currently in clinical use. De
Veld et al. provide an excellent review of the status of in vivo
autofluorescence imaging for oral oncology.8
While fluorescence imaging alone has shown great prom-
ise for detection of neoplastic lesions in the oral cavity, incor-
porating additional imaging techniques may increase the ef-
fectiveness and sensitivity of wide-field optical devices.
Techniques that are capable of detecting increases in vascular
density and changes in light scattering properties may be par-
ticularly useful, since these features have previously been as-
sociated with the development of cancer, and are not easily
detected by fluorescence imaging alone.18 Additionally, reflec-
tance imaging systems tend to be simpler in design compared
to fluorescence devices, thereby reducing instrument com-
plexity and cost. In narrow-band NB reflectance imaging,
tissue is illuminated using a 10 to 20 nm wavelength band
and reflected light is imaged. The optical contrast of mi-
crovasculature close to the epithelial surface can be increased
by selecting an illumination band that matches peaks in the
absorption spectrum of hemoglobin.19 Another approach to
increase contrast is to control the polarization of the illumina-
tion source and detected light. In orthogonal polarization re-
flectance OPR imaging, tissue is illuminated with linearly
polarized light; a second linear polarizer is placed in front of
the detector and oriented so that only reemitted light with a
polarization orthogonal to the illumination is captured. This
has the effect of selectively detecting photons that have un-
dergone multiple scattering events in the tissue resulting in a
reduction in degree of polarization and rejecting those singly
scattered photons returning from the surface of the tissue.
This technique enables observation of deeper or birefringent
tissue structures and enhances the prominence of microvascu-
lature due to increased hemoglobin absorption.20 When both
orthogonal and parallel polarization images are captured, they
can be mathematically combined to form a composite image,
which has been shown useful for imaging skin pathologies.20
Lindeboom et al. described orthogonal polarization spectral
OPS imaging of oral tumor sites using a magnifying hand-
held device coupled to a CCD camera, designed to provide
maximum contrast between the microvasculature and sur-
rounding tissue.21
The multispectral digital microscope MDM was devel-
oped to investigate the diagnostic effectiveness of combining
multiple imaging modalities in a single device. The MDM
acquires high-resolution, wide-field images in vivo, using
white light illumination, fluorescence excitation, NB, and
OPR modes. It employs a wide range of illumination wave-
lengths to investigate which provide the greatest contrast be-
tween normal and neoplastic areas for each imaging mode. In
this paper, we describe the design of the device, evaluate its
optical performance, and present sample images obtained in
human subjects with the MDM system.
2 Materials and Methods
2.1 Instrumentation
Figure 1 shows an optical schematic of the MDM. The
OPMI® picodental microscope Carl Zeiss, Jena, Germany is
used as the core optical component of the MDM. The magni-
fication setting is adjusted by turning a lens turret to one of
five positions. Light is routed from the source to the micro-
scope head by a fiber optic light guide. The working distance
of the microscope is 25 cm. The FOV of the device is depen-
dent on the choice of magnification setting and ranges be-
tween 1 and 4 cm in diameter. With a monitor size of 17 in.,
the system magnification ranges from 8.5 times to 34.7 times.
The original light source was replaced with an air-cooled
100-W mercury arc lamp Photon Technology International,
Birmingham, New Jersey, housed in a custom light box. The
lamp and ellipsoidal reflector produce a converging beam
which is collimated using a 25-mm planoconvex lens
Lambda Optics, Costa Mesa, California. To protect both the
patient and optical components from excessive heating, a cold
mirror Barr Associates, Westford, Massachusetts is used to
eliminate unwanted IR radiation, and an absorbing glass filter
removes UV light at wavelengths below 350 nm. The beam
then passes through a 10-position excitation filter wheel Sut-
ter Instruments, Novato, California and through a second pl-
anoconvex lens, which focuses the beam onto the proximal
face of a 5-mm-diam fused quartz light guide Fiberoptic Sys-
tems, Simi Valley, California, which routes the light to the
microscope head. Since the microscope was not originally
designed to support near-UV excitation, a custom-machined
adaptor was implemented to bypass the original illumination
optics and to hold the distal end of the light guide and a fused
quartz focusing lens Newport Optics, Stratford, Connecticut.
This adaptor provides a significant increase in near-UV exci-
tation power and subsequently reduces exposure times re-
quired for fluorescence imaging. The adaptor also holds a lin-
ear polarizer Chroma Technologies, Rockingham, Vermont,
which is servo controlled and engaged by the LabVIEW Aus-
tin, Texas interface.
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The illumination filter wheel contains narrow-band illumi-
nation filters at 420, 430, 530, and 600 nm for NB imaging.
These wavelengths were selected to match hemoglobin ab-
sorption features, and also to provide multiple wavelengths
throughout the visible spectrum to study the effects of wave-
length on penetration depth. The illumination filter wheel also
contains illumination filters centered at 365, 380, 405, and
450 nm for autofluorescence excitation. These excitation
wavelengths were chosen based on previous work by Hein-
zelman et al.13 and Utzinger et al.22 The full width at half
maximum FWHM transmission bandwidth for the excitation
filters ranges from 20 nm for NB imaging to 50 nm for UV
illumination Chroma Technologies, Omega Optics. A 1.0
neutral density filter is used to attenuate the white light illu-
mination power. A light-blocking disk occupies one position
in the excitation filter wheel and is used for measurement of
the background light level.
The emission arm of the MDM consists of a Zeiss objec-
tive lens and 50/25/25 beamsplitter, which passes 50% of the
emission light to the microscope eyepieces and 25% each to
two CCD detectors. An emission filter wheel Oriel Optics,
Stratford, Connecticut is located in one detection arm and
contains long-pass filters and a linear polarizer. A long-pass
filter with a cut-on at 410 nm is used with the 365- and
380-nm excitation, one with a cut-on at 430 nm is used with
405-nm excitation wavelength, and one with a cut-on at
475 nm is used with 450-nm excitation. An additional linear
polarizer is placed in the opposing detector arm, as shown in
Fig. 1. In one arm, the polarizer is oriented parallel to the
excitation polarizer and in the other, the polarizer is oriented
perpendicular to the excitation polarizer. The opposing polar-
izers enable simultaneous OPR and parallel polarization im-
aging; this feature is useful for reducing changes in FOV that
can occur due to patient movement.
Fig. 1 a MDM in the Head and Neck Clinic at the MD Anderson Cancer Center and b system optical schematic.
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Two Retiga Exi QImaging, Burnaby, BC, Canada 12-bit
color-cooled cameras are used to collect image data. This
camera model was chosen because of its low-light sensitivity
and compatibility with the LabVIEW programming environ-
ment. The sensor is a Sony ExHAD ICX285 progressive-scan
high-sensitivity CCD chip, providing adequate spectral sensi-
tivity at chosen wavelengths of interest, from 400 to 650 nm.
The chip is covered by a Bayer Mask mosaic for color imag-
ing. Image data are saved in raw Bayer format and color
interpolation is performed in postprocessing based on color-
balancing standards.
Control of the MDM system is accomplished by a custom
LabVIEW graphical interface. The interface provides the op-
erator with the ability to image with one excitation/emission
wavelength pair at a time, or to collect a rapid sequence of
image data over the range of the MDM’s capabilities. The
interface also enables the user to store information such as
study number and patient data, which are linked and saved
with the optical data. Imaging parameters are recorded for all
data collected, and background measurements are taken with
each sequence.
The MDM takes about 1 min to collect a complete image
sequence. The sequence is composed of white light reflec-
tance, fluorescence, NB, OPR, parallel polarization reflec-
tance, and background data sets. A predefined set of exposure
and gain settings was established for each image in the se-
quence based on measurements of normal volunteers. To ac-
count for interpatient variability, measurement site variability,
and changes due to disease, the predefined set of exposure
times could be manually scaled up or down in 20% intervals
during imaging. Additionally, four duplicate images were
taken for each illumination/emission setting at lower and
higher exposure times relative to the initial choice. Table 1
shows typical exposure times based on the most commonly
used exposure settings used in the pilot clinical trial.
A set of standards was chosen to quantify the performance
of the MDM as well as to track any changes occurring in the
device over time. Positive reflectance standards include 99,
75, and 50% reflectance spectralon disks Labsphere, North
Sutton, New Hampshire, and red, green, and blue portions of
a Macbeth Color Chart GretaMacbeth LLC, New Windsor,
New York. A 2% spectralon disk serves as a negative reflec-
tance standard. Positive fluorescence standards include a set
of four fluorescent slides Microscopy/Microscopy Education,
microscopyeducation.com and the negative fluorescence
standard is a frosted quartz disk Mark Optics, Santa Ana,
California.
For white light illumination, color balance was achieved
by imaging a white balance sheet and adjusting the RGB ratio
in software so that equal pixel intensity values were obtained
in the red, green, and blue channels. For fluorescence imag-
ing, a constant color balance was used throughout the study to
maximize qualitative diagnostic ability and to reflect the natu-
ral blue-green tissue fluorescence color. The fluorescence
color slides were used as a standard to track any changes in
color response of the camera over time in fluorescence mode.
2.2 Pilot Clinical Study
Several sites within the oral cavity of normal subjects were
imaged using the MDM as part of an Institutional Review
Board IRB-approved protocol at Rice University. In a sepa-
rate, ongoing pilot clinical study conducted at the University
of Texas M. D. Anderson Cancer Center MDACC, the
MDM was used to image clinically abnormal and normal oral
mucosal sites in patients. This protocol was approved by the
IRBs at both Rice University and MDACC.
The measurements were performed either in the outpatient
clinic or in the operating room on patients under general an-
esthesia prior to surgery. The areas to be imaged were chosen
by the clinician and included areas that had previously been
identified as abnormal by clinical examination and/or biopsy.
The physician first evaluated these targeted areas using the
MDM under white light illumination, adjusting the focus and
FOV. Several measurement sequences were then taken from
each subject including abnormal sites, and when possible, a
corresponding contralateral normal site. Excess saliva was
suctioned prior to imaging. Because teeth exhibit particularly
strong autofluorescence, attempts were made to cover any
teeth in the FOV with low-fluorescence gloves or a mouth
guard. The head of the patient was positioned and held by the
physician during imaging to reduce motion artifacts. In pa-
tients seen in the clinic, biopsies were obtained from clinically
abnormal sites and a contralateral normal site. In patients who
underwent surgical excision, the resected specimens were his-
tologically examined. A clinical diagnosis for normal and
abnormal-appearing areas graded as normal, abnormal but
not suspicious for neoplasia, suspicious for neoplasia, or can-
cer was rendered by the clinician. The histopathology diag-
nosis of biopsy sites and resected tissue from imaged areas
were considered the gold standard for diagnosis.
Four observers DR, CK, AG, RRK examined the images
to identify features that differed in abnormal sites compared to
clinically normal areas, and which might be further explored
for diagnostic relevance. Qualitative observations of image
data were correlated with clinical observations regarding pe-
Table 1 Irradiance and typical exposure times for each illumination
condition.
Illumination,
 nm
Imaging
Modality
Irradiance
mW/cm2
Typical
Exposure
ms
365 fluor. 11.15 100
380 fluor. 8.86 160
405 fluor. 7.00 400
450 fluor. 5.10 500
white reflect 12.02 16
420 reflect 3.13 64
430 reflect 9.62 13
530 reflect 1.91 24
600 reflect 4.17 64
white, polarized polarized 11.15 100
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ripheral extent of abnormal changes and clinical diagnostic
category. Pathology results from resected tissue and biopsies
enabled comparison between MDM image data and histo-
pathologic diagnosis of lesions.
3 Results
3.1 Instrument Performance
The resolution of the MDM was determined by imaging a
U.S. Air Force USAF spatial resolution target, as shown in
Fig. 2. A line spacing of 15.6 m group 5, element 1 can
clearly be discriminated at the highest magnification. The ap-
pearance of shadowing behind each element is due to the
finite thickness of the glass substrate, and is not intrinsic to
the MDM system. Measurements of white light illumination
on a 99% reflectance spectralon standard Labsphere, North
Sutton, New Hampshire show a 4-cm-diam illumination spot
size. This is adequate to illuminate all but the edges of the
FOV at the most commonly used magnification. The illumi-
nation pattern is Gaussian due to light guide coupling.
To confirm the absence of excitation filter leakage and ad-
equacy of performance of longpass filters, a 2-in.-diam frosted
quartz disk was imaged in fluorescence mode. Exposure times
and gain settings matching or exceeding those used for nor-
mal tissue fluorescence imaging were used at each excitation/
emission wavelength pair to confirm the absence of signal
from the nonfluorescent frosted quartz disk. The ratio of au-
tofluorescence signal from tissue to frosted quartz was always
greater than 10:1.
Intrasequence image registration was affected by patient
movement, generally causing some changes in the FOV dur-
ing the course of the image sequence. Figure 4 in Sec. 3.3
shows several images taken from a typical sequence in a clini-
cal setting at the most common magnification setting. Using
user-defined selection of points common to both images, the
linear translation was less than 60 pixels less than 5% of the
FOV between any two of the images in the sequence in both
the x and y directions.
UV radiation during all human measurements is well be-
low the American Conference of Governmental Industrial Hy-
gienists maximum allowed rating.23
3.2 MDM Images of Normal Oral Sites
Sites imaged in the oral cavity from four normal volunteers
included tongue, buccal, lip, gingiva, hard palate, soft palate,
and floor of mouth. Fine vasculature was clearly identifiable
in images acquired from the lip, floor of mouth, hard palate,
and soft palate using white light, NB, OPR and fluorescence
techniques. These images serve as further examples of the
resolution capabilities of the MDM. Figure 3 shows an image
of the lower lip of a normal volunteer under several illumina-
tion conditions. The white light image Fig. 3A shows mi-
crovasculature from a variety of depths beneath the epithelial
surface. The OPR image illustrates similar vascular patterns;
specular reflection is no longer visible in the image, and spa-
tial resolution is somewhat reduced because the OPR tech-
nique selectively records photons that have undergone more
scattering events in the tissue. The NB image obtained with
420-nm illumination Fig. 3B shows only the superficial,
fine vasculature due to the reduced penetration of this wave-
length; vessel contrast is also increased because this wave-
length matches the Soret absorption band of hemoglobin. As
the illumination wavelength is increased from green Fig.
3D to red Fig. 3F, vessels deeper within the tissue are
visible in the image. The NB image obtained with 600-nm
illumination shows a loss of contrast and spatial resolution
due to the increased ratio of scattering to absorption and in-
creased mean free path between scattering events at this
wavelength. Vasculature was not as apparent in the buccal and
tongue.
Tissue autofluorescence is predominantly blue at UV exci-
tation wavelengths Fig. 3E and blue-green at the longer
450 nm excitation. The hard palate, soft palate, floor of
mouth, and buccal mucosa provided a higher fluorescence sig-
nal than the tongue, gingiva, and lip. The midline of the hard
palate was particularly bright. Teeth were highly fluorescent
and tooth fluorescence could be seen through portions of the
gingival mucosa. Blood vessels appeared dark under fluores-
cence mode compared to the surrounding tissue. Red fluores-
cence occasionally appeared on the dorsal tongue.
3.3 MDM Images of Oral Dysplasia and Cancer
Images of a premalignant lesion and an invasive cancer are
presented as representative examples to demonstrate the capa-
bilities of the MDM system for examination of the oral cavity.
Some images were cropped to only show relevant areas.
Figure 4 shows images obtained from a thin leukoplakia
lesion indicated by arrows on the right mandibular gingiva.
The thin leukoplakia in the OPR image Fig. 4C is less
evident demonstrating the ability of OPR imaging to selec-
tively detect photons that have scattered more deeply into the
tissue. The blue NB image Fig. 4D shows the leukoplakia
as brighter in reference to surrounding tissue compared to the
white light image.
Figure 5 shows images acquired from a subtle lesion on
the right lateral tongue. The clinical impression of the lesion
was leukoplakia, but not overly suspicious for dysplasia or
cancer. Following imaging, a 2.41.00.4 cm3 volume was
surgically resected and histopathology showed moderate
squamous dysplasia Fig. 5H. The standard white light im-
age Fig. 5A shows some patchy irregularities in the mu-
cosal surface. Using the green NB Fig. 5E and the OPR
imaging conditions Fig. 5C, an apparent increase in visual
contrast was observed between the lesion and surrounding
normal areas indicated by arrows in each case. A decreased
blue/green autofluorescence DA was observed in the area of
the lesion in fluorescence images at 365-, 380-, and 405-nm
Fig. 2 USAF resolution target imaged at high magnification. Element 5
group line spacings of 15.6 m shown in the dashed box are easily
discriminated in the zoomed-in image on the right.
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Fig. 3 Images of normal volunteer inner lip: A white light illumination image, B 420-nm NB image, C OPR image, D 530-nm NB image, E
365-nm excited fluorescence image, and F 600-nm NB image. Note increased contrast of vasculature in C compared to white light image. Fine
vasculature is visible in B, whereas deep, larger diameter vasculature is visible in F. Scale bars indicate 0.3 cm.
Fig. 4 Images of leukoplakia lesion on right gingiva: A white light illumination image, arrows indicate area of leukoplakia; B parallel polariza-
tion image; C OPR image; and D 420-nm NB image. Note that the OPR C enables visualization of tissue below the thin leukoplakia and the
420-nm OPR image D accentuates areas of leukoplakia. Scale bars indicate 0.25 cm.
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excitation Figs. 5B, 5D, and 5F. An image of a con-
tralateral normal area imaged using white light is shown in
Fig. 5G for comparison.
Figure 6 shows images acquired from a premalignant le-
sion on the left lateral tongue. The clinical impression was
erythroplakia; a reddish lesion associated with a high risk of
dysplasia or early carcinoma. Histopathology from a biopsy
of the lesion indicated severe squamous dysplasia with a focal
ulceration and chronic inflammation Fig. 6H. Both the
OPR image Fig. 6C and the green NB image Fig. 6E
showed an area of abnormality appearing darker red on OPR
and darker on NB images as indicated by arrows, which is
more extensive in peripheral extent and has increased contrast
as viewed against the surrounding mucosa. In the images ob-
tained using all four fluorescence excitation wavelengths a
comparative decrease or loss of blue or green fluorescence
was seen in the abnormal site. The total area of DA was larger
at 405-nm excitation Fig. 6F than at 365-nm Fig. 6B
and 380-nm excitation Fig. 6D. In addition, a striking ring
of increased red fluorescence surrounding the lesion was ob-
served in the fluorescence images, and is most apparent at
405-nm excitation. This red fluorescence is consistent with the
presence of endogenous porphyrins. A white light image ob-
tained from a contralateral normal area is shown in Fig. 6G
for comparison.
Figure 7 shows images from the right lateral tongue in a
subject with histologically confirmed carcinoma. A previously
biopsied and ulcerative lesion is shown in the center of the
Fig. 5 Images from tongue of patient with leukoplakia, A to F show a FOV containing areas along the lateral aspect of the tongue, which were
resected and found to contain moderate dysplasia: A white light illumination image, B 356-nm excited fluorescence image, C OPR image, D
380-nm excited fluorescence image, E 530-nm NB image, F 405-nm excited fluorescence image, G white light illumination image of
contralateral normal site, H hematoxylin and eosin H&E-stained tissue from abnormal area indicating moderate dysplasia. Arrows indicate areas
with loss of fluorescence or increased contrast. Scale bars indicate 0.5 cm in A to G and 200 m in H.
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FOV. In the OPR image Fig. 7B, the blue NB image Fig.
7C, and the green NB image Fig. 7E, increased contrast
is noted by arrows in the tissue surrounding the ulcer. The
blue NB image Fig. 7C shows larger dark areas in the
ulcerative lesion and in the bottom right compared to the
white light image Fig. 7A. The red NB image Fig. 7G
shows smaller dark areas compared to white light. The fluo-
rescence images show a decrease of blue/green fluorescence
surrounding the ulcerative lesion, and this DA is more appar-
ent for 405- and 450-nm excitation Figs. 7F and 7H than
Fig. 6 Images from ventral tongue of patient with erythroplakia, A to F show a FOV of the left lateral tongue containing erythroplakia from
clinical appearance and severed dysplasia from histophathology of biopsy site: A white light illumination image, B 356-nm excited fluorescence
image, C OPR image, D 380-nm excited fluorescence image, E 530-nm NB image, F 405-nm excited fluorescence image, G white light
illumination image of contralateral normal site, and H H&E-stained tissue from abnormal area indicating severe dysplasia. Arrows indicate areas
with loss of fluorescence or increased contrast. Scale bars indicate 0.5 cm in A to G and 200 m in H.
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at 365-nm excitation Figs. 7D and 7E. Following imag-
ing, a 3.22.51.0 cm3 portion was resected and was de-
termined by histopathology to contain invasive squamous car-
cinoma centrally, with dysplasia near the margins of resection.
In these representative examples, we observe one or more
of the following features in areas histologically determined to
be abnormal: a decrease of blue/green fluorescence, increased
red fluorescence, and an increase of contrast in highly vascu-
lar regions. Blood on the surface of the tissue also appeared
dark compared to white light under blue and green NB illu-
mination. Teeth and gloves occasionally interfered with fluo-
rescence imaging of tissue due to their autofluorescence, as
can be seen in the lower left corner of the fluorescence frames
in Fig. 5.
4 Discussion
In this study, DA was observed in many clinically abnormal
areas compared to surrounding normal tissue, and this finding
was common to all four fluorescence excitation wavelengths.
DA was also observed surrounding submucosal, exophytic, or
hyperkeratotic abnormal areas as well as in clinical lesions
Fig. 7 Images from cancer on right lateral tongue: A white light illumination image, B OPR image, C 430-nm NB image, D 365-nm excited
fluorescence image, E 530-nm NB image, F 405-nm excited fluorescence image, G 600-nm NB image, and H 450-nm excited fluorescence
image. Arrows indicate increased contrast or decreased autofluorescence. Scale bars indicate 0.25 cm.
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lacking the white keratotic surface associated with leuko-
plakia. Areas with DA did not always correspond to areas
where increased contrast was seen using other modalities. In-
creased red fluorescence was observed in about half the pa-
tients imaged. It appeared most often on cancerous regions
and on necrotic tissue but occasionally appeared in clinically
dysplastic or precancerous areas. Red fluorescence did not
usually correlate with DA or with increased contrast from NB
or OPR imaging.
Blue and green NB images tended to increase contrast of
visible blood vessels and areas suspected of containing a high
density of superficial microvasculature. Blue illumination re-
vealed fine vasculature, which appeared superficial, whereas
illumination at green or red wavelengths revealed larger di-
ameter, deeper vasculature. The 530-nm illumination was
most useful in increasing negative contrast in lesions in the
study patients. Blood on the surface of the tissue also ap-
peared dark under blue and green NB excitation. OPR had the
effect of reducing specular reflection and increasing negative
contrast in some abnormal regions compared to imaging un-
der conventional white light illumination. Both OPR and NB
appear useful for detecting areas with high microvascular den-
sity, and in many cases, the resulting images showed extended
margins of clinically abnormal areas compared to white light
imaging. In most cases, discrete vessels were observed in nor-
mal contralateral measurements and at the periphery of abnor-
mal areas, while diffuse, homogeneous red areas were ob-
served on abnormal lesions with flat contours. Elevated
lesions in cancerous or precancerous areas often obscured
vascular detail.
The characteristic DA associated with neoplasia has been
extensively explored to determine abnormal areas in previous
imaging studies in the oral cavity.6,15,17,24 It has been sug-
gested that a decrease of collagen cross-links and decreased
density of matrix fibers is the major contributor to loss of
green fluorescence; these are important features that may be
associated to malignant progression. Pavlova et al.25 and
Drezek et al. have shown that precancerous cervical tissue
exhibits decreased stromal fluorescence due to a decreased
density of matrix fibers. Lane et al., who used excitation light
from 400 to 460 nm, suggest collagen-related DA as a major
mechanism enabling contrast between the appearance of neo-
plastic areas and normal tissue using6,26 the Velscope®.
Increased red fluorescence in the oral cavity is well docu-
mented for carcinoma, and in previous imaging
studies,12,14,17,27 red fluorescence was best observed when ex-
cited at approximately 410 nm. Inaguma and Hashimoto
found the presence of red fluorescence in 85% of the 78 le-
sions of oral carcinomas they investigated.12 Ingrams et al.
obtained 90% sensitivity and 91% specificity for the discrimi-
nation of normal and dysplastic/malignant mucosa using the
presence of red fluorescence.28 This red fluorescence is gen-
erally attributed to the presence of porphyrins whose origins
in biological tissue are disputed. It is unclear whether they are
a by-product of abnormal metabolism in tissue or if it is pro-
duced by bacteria contaminating the surface of the tissue.
Changes in contrast using NB and OPR have been previ-
ously observed in oral tissue and are likely due to increased
microvasculature density and structure associated with malig-
nant transformation. Pazouki et al. showed an increase in vas-
cularity in oral tissue throughout malignant progression.18 By
choosing reflectance excitation wavelengths that correspond
to hemoglobin spectral features, the NB reflectance images
maximize microvasculature visualization and contrast. Sub-
hash et al. used this technique to detect abnormal tissue in the
oral cavity. They showed that the ratio of two oxygenated
hemoglobin dips at 540 and 575 nm decreased in excised
malignant tissue compared to normal.19 De Felice et al. specu-
lated that observed optical changes in the color spectrum ob-
served in bronchopulmonary dysplasia may be caused by an
altered microvasculature network.29 Wavelength-dependent
photon penetration depth utilized in NB reflectance imaging
may also provide useful depth dependent diagnostic informa-
tion.
OPR techniques enabled us to look deeper into tissue by
utilizing the ability to reject singly scattered photons that have
retained their polarization state. Photons that have had their
polarization state altered either by multiple scattering events
or by birefringent properties of the tissue are selectively de-
tected. This can have the effect of providing negative contrast
against surrounding tissue when imaging vasculature, and of
making vasculature networks lying deep to the surface appear
visible. Lindeboom et al.21 used orthogonal polarization spec-
tral imaging to observe vascular patterns in patients with oral
SCC. They found that in 80% of the cases from 10 patients,
capillary density was increased in tumorous areas and in 90%
of the cases, disarrangement of capillary morphology corre-
lated with tumorous areas.
This pilot trial was designed to demonstrate the capabili-
ties of the MDM as well as to make preliminary qualitative
observations of abnormal lesions in humans. Further studies
of larger groups of patients are required to determine the util-
ity of each imaging technique compared to white light inspec-
tion, as well as to determine which combinations of tech-
niques afford the most useful predictive information.
Contributions from inflammation or benign conditions to DA
or increased contrast in NB imaging will affect the specificity
of detection and it will be important to determine these ef-
fects. Additionally, precise pathology correlations will be key
to future studies. Correlations in this study were made using
histopathologically diagnosed biopsy or resected tissue data
that were known to be within the FOV during image collec-
tion. Biopsy data provide information on only a small fraction
of the imaged FOV and represents a limitation of this pilot
study. Improved techniques for spatial correlation between
histopathologic sections and image data will be required in
future work.
The MDM described here can obtain high-quality images
of the oral cavity using multiple imaging modalities. To fa-
cilitate comparison between modalities, images were col-
lected in rapid sequences from the same FOV. Pilot clinical
data indicate that additional imaging modalities such as NB
and OPR may provide information not available in fluores-
cence mode alone, and may be useful in discriminating pre-
cancerous and cancerous tissue from normal and benign or
inflammatory regions.
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